AdvertisementAdvertise with NZME.
Latest fromFisher & Paykel Health
Stock Takes: What’s eating Fisher & Paykel Healthcare?
Since June 30, Fisher & Paykel Healthcare's stock has fallen by 14 per cent.
F&P Healthcare cleared for $275m land deal, 104ha expansion
The new site will be a second R&D and manufacturing campus to grow operations.
Covid boost: Kiwi healthcare company's first-half profit leaps 86%
Fisher and Paykel Healthcare has lifted its first half net profit.
F&P Healthcare overvalued at current price - Forsyth Barr
The investment group anticipates that the company's share price could sink back down.
Stock Takes: NZX's Fang stocks long in the tooth?
Our take on what is happening on the markets this week.
Healthcare trends promise revenue boost
Fisher & Paykel Healthcare's sales could be nudging the $2 billion mark within a decade if the company's bullish growth projections become a reality.
Kiwi tech firms take on global market
New Zealand's technology sector is booming, with more companies going global, raising capital and expanding than at any time since the Global Financial Crisis.
Stock Takes: Good prognosis for F&P Healthcare
Fisher & Paykel Healthcare reported yet another record full-year profit last Friday, justifying Craigs' consistently bullish view.